| Lessons learned from quantitative dynamical modeling in systems biology A Raue, M Schilling, J Bachmann, A Matteson, M Schelke, D Kaschek, ... PloS one 8 (9), e74335, 2013 | 393 | 2013 |
| Quantitative systems pharmacology modeling provides insight into inter‐mouse variability of anti‐CTLA4 response W Qiao, L Lin, C Young, J Narula, F Hua, A Matteson, A Hooper, ... CPT: Pharmacometrics & Systems Pharmacology 11 (7), 880-893, 2022 | 7 | 2022 |
| Methods and systems for analyzing datasets A Matteson US Patent 10,445,341, 2019 | 7 | 2019 |
| Early feasibility assessment: A method for accurately predicting biotherapeutic dosing to inform early drug discovery decisions DH Marcantonio, A Matteson, M Presler, JM Burke, DR Hagen, F Hua, ... Frontiers in Pharmacology 13, 864768, 2022 | 4 | 2022 |
| A systems pharmacology model for gene therapy in sickle cell disease B Zheng, L Wille, K Peppel, D Hagen, A Matteson, J Ahlers, J Schaff, ... CPT: Pharmacometrics & Systems Pharmacology 10 (7), 696-708, 2021 | 4 | 2021 |
| Methods and apparatus for therapeutic feasibility assessment using quantitative systems pharmacology and rule-based reasoning systems JF Apgar, JM Burke Jr, DC Flowers, DR Hagen, AL Matteson, JC Schaff US Patent App. 17/713,942, 2022 | 3 | 2022 |
| Optimizing ELECTRA-based model for Zero Anaphora Resolution J Park, M Choi, A Matteson, C Lee Annual Conference on Human and Language Technology, 329-334, 2021 | 2 | 2021 |
| Methods and systems for calculating joint statistical information A Matteson US Patent App. 14/733,477, 2015 | 1 | 2015 |
| Computational Methods in Model Merging with Applications to Pharmaceutical Development A Matteson New York University, 2013 | 1 | 2013 |
| An enzyme kinetic model of blood island formation A Matteson Mathematical Medicine and Biology: A Journal of the IMA 25 (3), 233-245, 2008 | 1 | 2008 |
| Comparison of dose selection based on target engagement versus inhibition of receptor–ligand interaction for checkpoint inhibitors SA Head, C Johnson, S Sarkar, A Matteson, DH Marcantonio, F Hua, ... CPT: Pharmacometrics & Systems Pharmacology, 2024 | | 2024 |
| Methods and systems for analyzing discrete-valued datasets A Matteson US Patent 10,394,898, 2019 | | 2019 |
| Computational exploration of mechanistic determinants of ADC pharmacokinetics using QSP modeling strategies AK Wilkins, A Matteson, L Gruenbaum, J Park, JM Burke, JF Apgar Cancer Research 78 (13_Supplement), 4266-4266, 2018 | | 2018 |
| Computational exploration of mechanistic determinants of antibody drug-conjugate pharmacokinetics using quantitative systems pharmacology modeling strategies AK Wilkins, A Matteson, L Gruenbaum, J Park, JM Burke, J Apgar Cancer Research 77 (13_Supplement), 4061-4061, 2017 | | 2017 |
| Computational exploration of mechanistic determinants of antibody drug-conjugate pharmacokinetics using quantitative systems pharmacology modeling strategies. JM Burke, AK Wilkins, A Matteson, L Gruenbaum, JF Apgar Journal of Clinical Oncology 35 (15_suppl), e14000-e14000, 2017 | | 2017 |
| Abstract PR12: A model of HGF and EGF dual ligand stimulation in ACHN cells constructed with the aid of a novel model merging heuristic AL Matteson Cancer Research 72 (13_Supplement), PR12-PR12, 2012 | | 2012 |
